Soleno Therapeutics (SLNO) Interest & Investment Income (2013 - 2026)
Soleno Therapeutics' (SLNO) quarterly Interest & Investment Income came in at $4.9 million in Q1 2026, up 47.91% year-on-year from $3.3 million in Q1 2025, and down 3.96% on a QoQ basis from $5.1 million in Q4 2025.
Soleno Therapeutics (SLNO) Interest & Investment Income (2013 - 2026) Analysis & Trends
Soleno Therapeutics (SLNO) has 7 years of Interest & Investment Income data on file, last reported at $4.9 million in Q1 2026.
- On a quarterly basis, Interest & Investment Income rose 47.91% year-over-year to $4.9 million in Q1 2026; TTM through Mar 2026 was $18.5 million, a 39.4% increase from a year earlier, with the FY2025 full-year figure at $17.0 million, up 40.66% from the prior year.
- Interest & Investment Income for Q1 2026 stood at $4.9 million, down from $5.1 million in the prior quarter.
- Over the last five years, Interest & Investment Income for SLNO reached as high as $5.3 million in Q3 2025 and fell as low as $113000.0 in Q1 2023.
- Historically, Interest & Investment Income has averaged $2.8 million across 4 years, with a median of $3.2 million in 2025.
- Across the five-year window, Interest & Investment Income soared 1966.67% in 2024 and rose 5.94% in 2025, its largest moves.
- Year by year, Interest & Investment Income stood at $2.1 million in 2023, then jumped by 56.95% to $3.4 million in 2024, then soared by 52.45% to $5.1 million in 2025, then declined by 3.96% to $4.9 million in 2026.
- Per Business Quant data, the three most recent Interest & Investment Income figures were $4.9 million in Q1 2026, $5.1 million in Q4 2025, and $5.3 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 48.00 Mn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 19.51 Mn |
| 10 | Soleno Therapeutics | 874.25 Mn | 618.67 Mn | 93.41 Mn | 4.93 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 4.93 Mn |
| Dec 31, 2025 | 5.13 Mn |
| Sep 30, 2025 | 5.30 Mn |
| Jun 30, 2025 | 3.19 Mn |
| Mar 31, 2025 | 3.33 Mn |
| Dec 31, 2024 | 3.37 Mn |
| Sep 30, 2024 | 3.60 Mn |
| Jun 30, 2024 | 3.01 Mn |
| Mar 31, 2024 | 2.08 Mn |
| Dec 31, 2023 | 2.14 Mn |
| Sep 30, 2023 | 174,000.00 |
| Jun 30, 2023 | 147,000.00 |
| Mar 31, 2023 | 113,000.00 |
| Sep 30, 2017 | 4,000.00 |
| Jun 30, 2017 | 3,000.00 |
| Mar 31, 2017 | 1,000.00 |
| Dec 31, 2014 | 85.00 |
| Dec 31, 2013 | 772.00 |